In Mycobacterium tuberculosis-infected macrophages, cyclooxygenase-2 (COX-2) expression considerably increases to defend the body against mycobacteria by regulating adaptive immunity and restoring the mitochondrial inner membrane. Moreover, in cancer cells, COX-2 enhances the autophagy machinery, an important bactericidal mechanism. However, the association between M. tuberculosis-induced COX-2 and autophagy-mediated antimycobacterial response has not been explored. Here, COX-2 expression silencing reduced the autophagy and bactericidal activity against intracellular M. tuberculosis, while COX-2 overexpression reversed the above effects. In addition, enhancement of bactericidal activity was suppressed by inhibiting autophagy in COX-2-overexpressing cells, indicating that COX-2 accelerated mycobacterial elimination by promoting autophagy. Furthermore, the regulatory effects of COX-2 on autophagy were mediated by its catalytic products, which functioned through inhibiting the protein kinase B/mammalian target of rapamycin pathway. Thus, COX-2 contributes to host defense against mycobacterial infection by promoting autophagy, establishing the basis for development of novel therapeutic agents against tuberculosis by targeting COX-2.
Tuberculosis, caused by Mycobacterium tuberculosis, kills >1 million people worldwide annually and remains a major threat to global health [1] . As the first line of antimycobacterial immune defense, macrophages not only play a critical role in regulating the effective immune responses against M. tuberculosis [2, 3] but also serve as a preferred habitat for the pathogen [4] . M. tuberculosis persists in macrophages by interfering with the maturation of phagolysosome, escaping from degradation by lysosomal hydrolysis and preventing subsequent antigen presentation [5] . To tackle the survival strategy of mycobacteria, host macrophages promote maturation of the mycobacterial phagosome by initiating autophagy [6, 7] .
As a highly conserved and essential physiological process in most eukaryotic cells [8] , autophagy can be activated by various factors, such as starvation, rapamycin treatment, cytokine induction, and pathogen infection [9] . Upon M. tuberculosis infection, autophagy-related gene family proteins participate in autophagosome membrane elongation, while microtubule-associated protein light chain 3-I (LC3-I) is converted into LC3-II, located on both sides of the autophagosome membrane. Then, autophagosomes load the pathogen (or its macromolecules and abandoned organelles) and deliver it to lysosomes for accelerating mycobacterial degradation [10] [11] [12] . During the activation of autophagy, the mitogen-activated protein kinase/c-Jun N-terminal kinase, phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), and mammalian target of rapamycin (mTOR) signaling pathways are considered primary autophagy-regulatory pathways [13] [14] [15] . Activation of the PI3K/AKT pathway directly initiates the mTOR signaling pathway to negatively regulate uncoordinated 51-like kinase 1, which participates in autophagic responses in a variety of cell stress conditions, leading to inhibition of autophagy [16] . In addition, the enhanced intracellular survival protein secreted by M. tuberculosis inhibits autophagy by activating the AKT/mTOR pathway, contributing to mycobacterial persistence in host macrophages [17] .
Mycobacterial infection results in increased expression of cyclooxygenase-2 (COX-2), the key rate-limiting enzyme in the arachidonic acid pathway [18] . COX-2 is known to assist the antimycobacterial immune response via 3 mechanisms. First, COX-2 catalysis promoted by interleukin 1 yields increased levels of the reaction product prostaglandin E2 (PGE2), which cooperates with interleukin 1 to limit excessive type I interferon production and prevent the death of Mycobacterium-infected mice during the acute phase of infection [19] . Second, increased levels of COX-2 and PGE2 yielded by blockage of the 5-lipoxygenase pathway help macrophages activate CD8 + T cells through dendritic cell-dependent cross-priming during M. tuberculosis infection [20] .
Third, increased COX-2 expression repairs plasma membrane disruption, preventing necrosis of host cells and mycobacterial escape [21] , promoting apoptosis of host macrophages, and enhancing antigen presentation by infected macrophages [22] . Therefore, inhibition of COX-2 expression by M. tuberculosis is important in the pathogen's resistance to the immune response in host macrophages [23] .
COX-2 transforms arachidonic acid into PGH2, which is converted into other PGs (including PGD2, PGE2, PGF2α, PGI2, and PGJ2) by other isomerases. Each PG interacts with its receptor and activates different signaling pathways to regulate immune response, cell growth, metabolism, and cellular homeostasis [24] . PGE2α, PGF2, and PGJ2 enhance autophagy in cancer cell development [25] [26] [27] .
Both COX-2 and autophagy are important in bactericidal processes, but their association during mycobacterial infection remains unknown. Here, we explored the interplay between COX-2 and autophagy in M. tuberculosis-infected macrophages and its effect on intracellular mycobacterial survival. Intriguingly, our results revealed a novel role of COX-2 in regulating macrophage autophagy during mycobacterial infection, improving the overall understanding of host defense mechanisms against this pathogen.
METHODS

Ethics Statement
All animal experiments were approved by the Ethics Committee at Southern Medical University.
Reagents, Bacterial Strains, and Infection
Reagents are specified in the Supplementary Materials. Bacillus Calmette-Guerin (BCG) and M. tuberculosis H37Rv (American Type Culture Collection) were cultured in Middlebrook 7H9 broth with 10% BBL Middlebrook oleic acid-albumin-dextrose-catalase (OADC) enrichment at 37°C under 5% CO 2 . Mycobacteria were grinded to generate a single bacterium suspension in Dulbecco's modified Eagle's medium (DMEM). The density of bacteria was measured at OD 600 , and macrophages were infected at specified multiplicities of infection (MOIs).
Cell Culture
Murine bone marrow-derived macrophages (mBMDMs) were isolated from 4-6-week-old C57/6BL mice purchased from the Southern Medical University Animal Experimental Center (Guangzhou, China) and cultured in DMEM with 10% fetal bovine serum and 100 ng/mL granulocyte-macrophage colony-stimulating factor. Fresh medium was provided on days 3 and 5 of culture. After 7 days of culture, cells were used for further in vitro studies. A RAW264.7 green fluorescent protein (GFP)-LC3 stable cell line (preserved in our institute) and RAW264.7 cells (American Type Culture Collection; TIB-71) were grown in DMEM supplemented with 10% fetal bovine serum.
RAW264.7-COX-2 Stable Cell Line
We cloned DNA fragments of COX-2 from the murine gene Ptgs2 (GenBank accession number NM_011198.3) into the plasmid pHAGE-fullEF1a-MCS-IzsGreen, and lentiviruses carrying the sequence of Ptgs2 were obtained. After RAW264.7 cells were infected with lentiviruses (carrying Ptgs2) for 7 days, the positive cells were collected by flow cytometry (BD Biosciences, San Jose, CA). The RAW264.7 cells infected with the empty vector were used as control cells.
Short Interfering RNA (siRNA) and Transfection COX-2 siRNAs targeting NM_011198.3 were designed by RiboBio (Guangzhou RiboBio). A total of 150 nM of infected control or siRNA was transfected into cells by using Lipofectamine 2000 (Invitrogen) according to the manufacturer instructions.
hours. The infected cells were lysed in 1 mL of 0.01% Triton X-100 in water. The intracellular mycobacteria were grown on Middlebrook 7H10 agar plates with OADC for 3 weeks, and the mycobacterial colonies were counted.
Confocal Fluorescence Microscopy
Cells were grown on glass coverslips and treated with appropriate agents, after which they underwent fixation with 4% paraformaldehyde for 15 minutes, permeabilization with 0.2% Triton X-100 for 10 minutes, and blocking with 10% BSA-PBS for 40 minutes. The cells were incubated with primary antibodies overnight at 4°C. Excess primary antibodies was removed by washing with PBS, and cells were incubated with secondary antibodies for 40 minutes at room temperature. PBS was used to remove excess secondary antibodies. Nucleus was stained with 4,6-diamidino-2-phenylindole for 10 minutes at room temperature. Coverslips were mounted using ProLong Gold Antifade reagent (Invitrogen) and scanned by confocal microscopy with the Zeiss Axiovert LSM 880 instrument (Zeiss, Göttingen, Germany).
Statistical Analysis
Data were expressed as mean values ± standard errors of the mean. Statistical significance was determined by 1-way analysis of variance, and multiple comparisons were performed using the least significant difference post hoc test, when the variance between samples was equal, or the Dunnett T3 test, when the variance was not equal. A P value of <.05 was considered statistically significant. All statistical analyses were performed using SPSS statistical software, version 17.0 (SPSS, Chicago, IL).
RESULTS
Mycobacterium-Induced COX-2 Expression Contributed to the Defense
Against Intracellular Mycobacteria in Macrophages
COX-2 expression was tested in mBMDMs. After cells were infected with BCG and H37Rv at different MOIs and time points, messenger RNA and protein levels of COX-2 were analyzed. Results showed that both gene and protein levels of COX-2 increased dramatically in a time-dependent but not dose-dependent manner. Interestingly, protein level of COX-2 increased dramatically at 6 hours in BCG-infected cells, but it did not increase in H37Rv-infected cells for 16 hours ( Figure 1A and 1B). Furthermore, the role of COX-2 in mycobacterial survival in macrophages was investigated using a CFU assay. As shown in Figure 1C and 1D, silencing COX-2 expression significantly impaired the bactericidal activity of mBMDMs and increased the percentage of mycobacteria that survived 48 and 72 hours after infection. Similar results were observed in the murine macrophage cell line RAW264.7 ( Supplementary  Figure 1) . Moreover, after COX-2-silenced cells were infected with BCG for the indicated time, propidium iodide (PI) staining combined with flow cytometry showed no significant decrease in cell viability in the negative control and COX-2 siRNA transfection groups for 72 hours after infection (Supplementary Figure 2) , indicating that the increased bacterial survival caused by silencing of COX-2 expression was not attributed to the changes in cell viability.
Since elevation of COX-2 expression was delayed in H37Rv-infected macrophages ( Figure 1A and 1B), a COX-2-overexpressing cell line (RAW264.7-COX-2) was constructed to examine the vitality of H37Rv in the presence of high levels of COX-2, using a CFU assay. As we expected, consistent with the significantly increased COX-2 protein level as compared to that in the empty vector control (ie, RAW264.7-vector cells; Figure 2A ), the amount and survival of intracellular H37Rv significantly decreased by almost 2-fold in RAW264.7-COX-2 cells 48 and 72 hours after infection ( Figure 2B ). This suggested that COX-2 promoted macrophage defense against mycobacterial infection.
COX-2 Promoted the Maturation of Bacterium-Containing Phagosomes
We explored the mechanisms of COX-2 in mediating intracellular mycobacterial elimination. Mycobacterium organisms escape lysosomal bactericidal action by blocking the maturation of bacterium-containing phagosomes, as indicated by the colocalization of lysosomes and bacteria [5] . Thus, the colocalization of BCG and lysosomes marked with CD63 was examined. Results showed that the colocalization of BCG phagosomes and CD63 was remarkably reduced in COX-2-silenced cells ( Figure 3A ). Consistent with previous observations, the percentage of colocalizing BCG and CD63-expressing lysosomes was dramatically enhanced by 1.5-2-fold in RAW264.7-COX-2 cells ( Figure 3B ). This indicated that Mycobacterium-induced COX-2 expression contributed to the elimination of intracellular bacteria, promoting phagosomes maturation, which may involve autophagy.
Autophagy Was Enhanced by COX-2 in Mycobacterium-Infected
Macrophages
As previous studies reported, autophagy promotes the maturation of mycobacterial phagosomes and accelerates mycobacterial elimination [28] . We hypothesized that COX-2 enhances autophagy in infected macrophages and contributes to this process. The level of autophagic activity, indicated by the level of LC3-II, was evaluated, and the results showed that BCGand H37Rv-induced levels of LC3-II remarkably decreased in COX-2-knockdown mBMDMs ( Figure 4A ). The same results were observed in RAW264.7 cells (Supplementary Figure 3) . Moreover, LC3-II degradation can also result from the combination of mycobacterial autophagosomes and lysosomes [16] . To confirm the role of COX-2 in autophagy, a selective (V)-ATPase inhibitor, bafilomycin A1, was used to block luminal acidification and prevent LC3-II from autophagosomal degradation. We found that BCG-stimulated LC3-II was significantly inhibited A, Murine bone marrow-derived macrophages (mBMDMs) were infected with Bacillus Calmette-Guerin (BCG) at different times at a multiplicity of infection (MOI) of 2 or at different MOIs for 12 hours. COX-2 (coded by Ptgs2) messenger RNA (mRNA) and protein expression were assessed using quantitative reverse-transcription polymerase chain reaction analysis and Western blot. B, H37Rv was used to infect mBMDMs at different MOIs for 24 hours or at a MOI of 2 for the indicated time points. mRNA and protein expression of COX-2 were examined. C, mBMDMs were transfected with COX-2 small interfering RNA (siRNA) or negative control (NC) for 24 hours and infected with BCG (MOI, 2) for 12 hours. The protein level of COX-2 was examined by Western blot. COX-2-knockdown or NC-targeted mBMDMs were infected with BCG at a MOI of 10 for 1 hour. Ectocytic BCG was removed with phosphate-buffered saline, and the cells were cultured for 24, 48, and 72 hours. Colony-forming unit (CFU) assays were performed to determine the intracellular BCG number and the percentages of surviving mycobacteria as compared to the initial internalized bacteria in macrophages at different postinfection time points. D, After H37Rv was used to infect COX-2-knockdown or NC-targeted BMDMs for 24 hours, the protein level of COX-2 was examined by Western blot, and CFU assays were performed to determine the viability and survival of intracellular H37Rv. Experiments were performed 3 times, and data are shown as means ± standard errors of the mean. *P < .05, **P < .01, and ***P < .001.
in COX-2-knockdown cells treated with bafilomycin A1. These results confirmed the promotion of autophagy by COX-2 ( Figure 4A ). Furthermore, the association between COX-2 and autophagy was indicated by the assembling of LC3 puncta from diffusing points, which occurred following the activation of autophagy. Confocal microscopy showed that silencing of COX-2 expression significantly decreased the amount of LC3 puncta. Autophagy induction was examined in RAW264.7 cells stably expressing GFP-LC3 (RAW264.7-GFP-LC3 cells) and challenged with BCG after transfection with COX-2 siRNA. COX-2-silenced expression significantly reduced the amount of GFP-LC3 puncta ( Figure 4B) .
Moreover, the association between autophagy and COX-2 was assayed in RAW264.7-COX-2 cells. During H37Rv infection, the level of LC3-II was significantly increased in RAW264.7-COX-2 cells but not in RAW264.7-vector cells at the indicated time points ( Figure 4C) . Meanwhile, the number of LC3 puncta significantly increased in BCG-infected RAW264.7-COX-2 cells ( Figure 4D ). This indicated that the Mycobacterium-induced increase in the COX-2 level promoted autophagy.
Elimination of Intracellular Mycobacterium by COX-2 Occurred via
Autophagy
Since the foregoing results suggested the promotion of bactericidal activity and autophagy induction by COX-2, we investigated the direct association between COX-2-enhanced autophagy and bactericidal activity. First, the LC3 autophagosomes containing BCG in macrophages were examined. As expected, inhibition of COX-2 expression decreased colocalization of BCG and endogenous LC3 autophagosomes ( Figure 5A ). These results indicated that COX-2 strengthened the formation of mycobacterial autophagosomes. Then, 3-methyladenine (3-MA), a specific inhibitor of autophagy, was used to decrease the induction of autophagy in RAW264.7-COX-2 cells ( Figure 5B ). CFU counts indicated that the accelerated elimination of mycobacteria that was induced by COX-2 overexpression was dramatically abrogated by 3-MA both in BCG-infected and H37Rv-infected macrophages ( Figure 5C and 5D ). These data revealed that COX-2 induced the autophagy machinery to accelerate the elimination of intracellular mycobacteria.
COX-2 Enhanced Autophagy Process in Mycobacterium-Infected
Macrophages Through its Prostaglandin Products
COX-2 converts arachidonic acid to cyclic endoperoxidase and subsequently induces production of PGD2, PGE2, PGF2α, PGI2, and PGJ2 [18] . We explored whether PG mediated the promotion of autophagy. In BCG-infected COX-2-knockdown macrophages, PGD2, PGE, PGF2α, PGI2 [18] , and PGJ2 were used separately or in combination to treat cells. We observed that COX-2-inhibited cells had suppressed LC3-II levels when treated with a single PG (Supplementary Figure 4) . However, the inhibition of LC3-II caused by the silencing of COX-2 expression was reversed when all PGs were added as a mixture, even in negative control cells ( Figure 6A) . Surprisingly, the addition of the PG mixture without PGD2, which had no influence on LC3-II expression, did not reverse the suppression of LC3-II due to COX-2 inhibition (Supplementary Figure 4) . Thus, we speculated that several PGs (eg, PGD2 and PGI2) could not directly enhance autophagy but that synergistic effects existed among PG molecules to strengthen autophagy concertedly. Accordingly, all PGs were used as a mixture in subsequent experiments.
The role of the PG mixture in eliminating intracellular mycobacteria and autophagy was assayed in COX-2-knockdown macrophages. We found that suppression of mycobacterial elimination caused by the silencing of COX-2 expression was abolished by treatment with the PG mixture ( Figure 6B and 6C). Moreover, cell viability examined by PI staining did not change in all groups (Supplementary Figure 5) . When cells were treated with PGs, the decrease in GFP-LC3 puncta caused by COX-2 inhibition was reversed ( Figure 6D ). In addition, we demonstrated that mixed PGs, as the downstream products of COX-2, remarkably reversed the effects of COX-2 inhibition. Interestingly, PGs could not increase the level of LC3-II assays. Experiments were performed 3 times, and data are shown as means ± standard errors of the mean. *P < .05, **P < .01, and ***P < .001. Figure 6) , suggesting that PGs enhanced, rather than activated, the autophagy induced by mycobacterial infection.
in RAW264.7 cells without BCG infection (Supplementary
COX-2 Enhanced Autophagy by Inhibiting the AKT/mTOR Signaling
Pathway
Considering the role of exogenous PGs in promoting autophagy in uninfected macrophages (Supplementary Figure 6) , we considered the possibility that mycobacterial infection activated some negative regulatory pathways of autophagy that could be blocked by COX-2 and PGs. Because the AKT/mTOR signaling pathway negatively regulates autophagy and is activated during mycobacterial infection [29] , the level of AKT phosphorylation was examined in BCG-infected RW264. , 2) for 12 hours (left) and H37Rv (MOI, 2) for 24 h (middle). COX-2 and microtubule-associated protein light chain 3 (LC3) levels were detected by Western blot. COX-2 siRNA-transfected or NC-targeted mBMDMs were infected with H37Rv at a MOI of 2 for 20 hours and then incubated with bafilomycin A1 (BafiA1) at a concentration of 100 nM for 4 hours (right). COX-2 and LC3 levels were detected by Western blot, and all ratios of COX-2/GAPDH and LC3-II/GAPDH were calculated as shown in the representative blot. B, mBMDMs were transfected with COX-2 siRNA or NC and infected with BCG at a MOI of 10. The endogenous LC3 puncta were detected by confocal microscopy (left). The scale bar denotes 5 μm. The LC3 puncta (>1 μm) were quantified, and arrows indicate endogenous LC3 puncta. RAW264.7 cells stably expressing green fluorescent protein (GFP)-tagged LC3 (GFP-LC3) were transfected with COX-2 siRNA or NC for 24 hours and challenged with BCG at a MOI of 10 for 1 hour (right). GFP-LC3 puncta (>1 μm) were observed and counted under confocal microscopy. The scale bar denotes 5 μm, arrows indicate the GFP-LC3 puncta, and LC3 puncta were quantified. C, RAW264.7-COX-2 cells were infected with H37Rv (MOI, 2) at different times. LC3 and COX-2 protein expression was examined by Western blot. D, RAW264.7-COX-2 cells were challenged with BCG at a MOI of 10 for 1 hour. The ectocytic BCG was removed, and cells were cultured for 12 hours. The endogenous LC3 puncta were detected by confocal microscopy; the scale bar denotes 5 μm. A group treated with rapamycin (Rap), the activator of autophagy, served as a positive control. Results are shown as means ± standard errors of the mean from 3 independent experiments. DMSO, dimethyl sulfoxide. *P < .05, **P < .01, and ***P < .001. , 10) for 1 hour, and extracellular BCG was removed. After cells were cultured for 12 hours, the colocalization of BCG and microtubule-associated protein light chain 3 (LC3) was observed using confocal microscopy, and the colocalization of BCG and LC3-positive autophagosomes was quantified. Cells treated with rapamycin (Rap) were used as a positive control. The scale bar denotes 5 μm. Arrows indicate the colocalization of BCG and autophagosomes. B, In RAW264.7-COX-2 cells, 3-methyladenine (3-MA; 5 mM) was used for blocking autophagy, and LC3 and COX-2 expression was examined by Western blot. C, RAW264.7-COX-2 cells were pretreated with 3-MA for 1 hour and then infected with BCG. The viability of interacellular BCG was determined by colony-forming unit (CFU) assays. D, After H37Rv-infected RAW264.7-COX-2 cells were pretreated with 3-MA for 1 hour, the viability of interacellular BCG was determined by CFU assays. Data are shown as means ± standard errors of the mean from 3 independent experiments. DMSO, dimethyl sulfoxide. *P < .05, **P < .01, and ***P < .001. macrophages were infected with BCG for 10 and 30 minutes, but it was suppressed in RAW264.7-COX-2 cells and PG-treated macrophages ( Figure 7A) .
We examined the activation of mTOR signaling. After COX-2-silenced cells or RAW264.7-COX-2 cells were infected with BCG or H37Rv, the phosphorylation levels of mTOR and eukaryotic initiation factor 4E binding protein 1 (4E-BP1), the downstream substrate of mTOR signaling, were examined. We observed that the phosphorylation levels of mTOR and 4E-BP1 significantly increased in COX-2-knockdown cells but not in negative-control-targeted cells ( Figure 7B ). However, they decreased in RAW264.7-COX-2 cells but not in RAW264.7-vector cells ( Figure 7C ). mTOR and 4E-BP1 phosphorylation in COX-2-knockdown macrophages was blocked by treatment with the PG mixture ( Figure 7D ). Thus, Mycobacterium-induced COX-2 improved PG production and accelerated autophagy and bacterial elimination through the inhibiting AKT/mTOR signaling pathway.
DISCUSSION
Because of various survival strategies, M. tuberculosis is hard to eradicate [30] . However, host cells generate multiple Figure 6 . Exogenous addition of prostaglandins (PGs) reversed the effects mediated by silencing cyclooxygenase-2 (COX-2) expression. A, COX-2-silenced or negative control (NC)-targeted murine bone marrow-derived macrophages (mBMDMs) were infected with H37Rv for 15 hours and treated with a mixture of PGs for 9 hours. The level of microtubule-associated protein light chain 3 II (LC3-II) was determined by Western blot. The ratios of COX-2/GAPDH and LC3-II/GAPDH were calculated as shown in the representative blot. B, COX-2-silenced or NC-targeted mBMDMs were incubated with a PG mixture for 1 hour before Bacillus Calmette-Guerin (BCG; multiplicity of infection [MOI], 10) infection. Intracellular mycobacterial viability was determined by colony-forming unit (CFU) assays at different postinfection time points. The number of BCG was counted, and BCG survival was calculated. C, Viability and survival of intracellular H37Rv were determined by CFU assays after PG treatment. D, RAW264.7 cells stably expressing GFP-LC3 were transfected with COX-2 small interfering RNA (siRNA) or negative control (NC), pretreated with PGs for 1 hour, and infected with BCG (MOI, 10) for 1 hour. After extracellular BCG was washed away, cells were cultured for 12 hours, and green fluorescent protein (GFP)-tagged LC3 (GFP-LC3) puncta (>1 μm) were observed and counted under confocal microscopy. Rapamycin (Rap)-treated cells were the positive control. The scale bar denotes 5 μm. Arrows indicate the GFP-LC3 puncta. Independent experiments were performed 3 times, and data are presented as means ± standard errors of the mean. DMSO, dimethyl sulfoxide; NS, not significant. *P < .05, **P < .01, and ***P < .001.
biomolecules and activate different pathways, including COX-2 expression [19] , to resist intracellular M. tuberculosis infection [3] . As an inducible enzyme, COX-2 is normally absent in a wide variety of normal cells and tissues [31] but can be induced by the following stimuli: interleukin 1 secretion, pathogen infection, and lipopolysaccharide recognition [32, 33] . In this study, COX-2 was almost absent in uninfected macrophages, until macrophages were challenged with Mycobacterium organisms. Interestingly, high levels of COX-2 have different or even opposite effects in M. tuberculosis-infected cells and cancer cells (without infection). High COX-2 levels promote development of cancer by increasing levels of the antiapoptotic protein BCL-2 level and activating the mitogen-activated protein kinase pathway [34] . However, COX-2 can repair plasma membrane disruption resulting from M. tuberculosis infection, promoting bactericidal apoptosis [20] . Chen et al have suggested that, in H37Rv-infected human macrophages other than attenuated M. tuberculosis H37Ra-infected macrophages, COX-2 expression was inhibited and represented a benefit for mycobacterial survival (MOI, 10) [22, 23] . However, we found that COX-2 levels started to increase 16 hours after H37Rv infection, compared with 6 hours after BCG infection. Since COX-2 dramatically attenuated mycobacterial vitality in macrophages, we proposed that some unknown mechanisms were induced in the early stage of H37Rv infection that inhibited the antimicrobial activity of COX-2. However, further investigations are needed to elucidate these mechanisms. Furthermore, CFU assays showed that the proliferation of intracellular H37Rv persistently increased but that the viability of BCG was damaged 72 hours after infection, probably because of various survival strategies of H37Rv [30] .
Autophagy plays a central role in the innate immune responses against Mycobacterium organisms [11] . After mycobacteria are phagocytosed by macrophages, autophagy is activated to promote maturation of mycobacterial phagosomes and delivery of mycobacteria to the phagolysosome for degradation [12, 35] . Other effects of autophagy in the defense against mycobacteria have been investigated, including modulation of the inflammatory response during host defense against mycobacteria, such as increased tumor necrosis factor α production [36] , leading to T-cell activation by enhancing mycobacterial antigen presentation (Ag85B) [37] . We demonstrated that COX-2 induced the accumulation of LC3-II and the assembly of LC3 puncta in , and 70 minutes, and Western blot was used to determine the level of AKT phosphorylation. B, COX-2-silenced or negative control (NC)-targeted mBMDMs were infected with H37Rv (MOI, 2) for 24 hours, and levels of mTOR and 4E-BP1 phosphorylation were analyzed by Western blot. C, RAW264.7-COX-2 cells were infected with H37Rv (MOI, 2) for 12 hours. Western blot was used to examine the levels of mTOR and 4E-BP1 phosphorylation. D, After COX-2 small interfering RNA (siRNA) or negative control (NC) was transfected into mBMDMs, cells were pretreated with PGs for 1 hour and infected with H37Rv (MOI, 2) for 24 hours. The levels of mTOR and 4E-BP1 phosphorylation were analyzed by Western blot. Data are presented as means ± standard errors of the mean from 3 independent experiments. *P < .05, **P < .01, and ***P < .001.
Mycobacterium-challenged macrophages. Furthermore, owing to other proven antimycobacteria mechanisms of COX-2, when blocking autophagy with 3-MA, significant attenuation but not complete blockage of COX-2-mediated mycobacterial elimination in RAW264.7-COX-2 cells was observed. Interestingly, with the early secretory antigenic 6-kDa system 1 (ESX-1), autophagy was inhibited in dendritic cells infected with H37Rv but not those infected with H37Ra or BCG, to avoid antimycobacterial response [38] . In addition, COX-2 is inhibited in H37Rv-infected human macrophages, rather than in H37Ra infection [22, 23] . In this study, H37Rv-infected RAW264.7-COX-2 cells showed enhancement of autophagy and bactericidal ability. We conclude that inhibition of autophagy in H37Rv-infected macrophages may be attributed to suppression of COX-2 expression. COX-2 contributes to the catalysis of PG production, and each PG mediates various physiological processes by combining its receptors to activate several signaling pathway, such as the extracellular signal-regulated kinase (ERK), PI3K, and β-catenin pathways [24] . Under nicotine-induced cellular stress, PGE2 promotes autophagy in human cancer colon cells [25] . PGJ2 induces autophagy to promote death of a variety of cancer cells [27] , and PGF2α enhances the ERK1/2 pathway to induce autophagy in luteal cells [26] . In the present study, during mycobacterial infection, COX-2 knockdown negatively regulated autophagy, which was reversed by treatment with a mixture of PGs but not with a single PG. However, several reports have shown that each PG has different or even opposite physiological or immunological effects during the development of allergic lung inflammation and asthma [39] . For example, activation of downstream signal pathways of PGE2 is mediated by engagement of the PGE2 receptor with the following eicosanoid receptors (EPs) subtypes: EP1, EP2, EP3, and EP4 [40] . As a crucial PGE2 receptor, EP2 activates protein kinase A, whereas EP4 activates PI3K [41, 42] , but PGE2 signaling via the EP3 receptor counteracts the influence of EP2/EP4 during bacterial infection or inflammation [43] . We speculate that a compensation mechanism or physiological balance among PGs may explain why the inhibition of autophagy mediated by the silencing of COX-2 is reversed in cells treated with mixed PGs but not in those treated with a single PG or PGs without PGD2.
The AKT/mTOR pathway is considered to control cell growth and negatively regulate autophagy [31] in mycobacterial infection [29] . COX-2 and PGE2 activate the AKT/mTOR pathway and lead to cancer cell migration and invasion [44, 45] . However, the association between COX-2 and the AKT/mTOR pathway during mycobacterial infection remains unknown. We demonstrated that COX-2 promoted production of PGs to facilitate autophagy via abolishing the AKT/mTOR pathway in Mycobacterium-infected macrophages. As the impact of PGE2, PGJ2, PGF2α, PGD2, and PGI2 on the AKT/mTOR pathway in mycobacterial infection remains unclear, the mechanism by which COX-2 blocks AKT/mTOR pathway needs to be further investigated.
In conclusion, Mycobacterium-induced COX-2 promoted the process of autophagy by inhibiting the activity of the AKT/ mTOR pathway to suppress mycobacterial survival. Thus, we unraveled a novel and important role of COX-2 in autophagy regulation and mycobacterial elimination, and these results provided a novel perspective on therapeutic interventions for M. tuberculosis infection.
Supplementary Data
Supplementary materials are available at The Journal of Infectious Diseases online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author. 
